New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

Parkinson's disease is best treated when detected early, but the cost of those tests makes that difficult. A new, 3D-printed ...

Parkinson's may be due to environmental causes. One million people have the neurodegenerative disease that robs them of their ...

Researchers believe a usually harmless virus could trigger Parkinson’s disease. The Human Pegivirus (HPgV) belongs to the ...

Scientists in China have identified specific physical behaviours that could provide early warning signs for Parkinson's ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.

A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.

Video. A unique programme in Rio de Janeiro is helping people with Parkinson’s disease manage their symptoms through the art of capoeira.